Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosecurity

    American Ebola Patient Admitted to NIH Maryland Hospital

    By Global Biodefense StaffMarch 13, 2015
    NIH Clinical Center Special Clinical Studies Unit
    Share
    Facebook LinkedIn Reddit Email

    The National Institutes of Health (NIH) today admitted an American healthcare worker who has tested positive for Ebola virus disease to the NIH Clinical Center Special Clinical Studies Unit (SCSU) in Bethesda, Md.

    The individual acquired the disease while volunteering at an Ebola treatment center in Sierra Leone and was transported back to the United States in isolation via a chartered aircraft.

    NIH physicians have evaluated the patient and have determined that the patient’s condition is serious. No additional details about the patient are being shared at this time.

    The SCSU is a high-level containment facility staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola. In addition, access to the unit is strictly controlled.

    This will be the second patient with Ebola virus disease admitted to the NIH Clinical Center. An earlier patient was treated successfully and released free of disease. The NIH Clinical Center also admitted two individuals who experienced high-risk exposures to the Ebola virus while working on the Ebola response in West Africa, but who were ultimately found not to be infected.

    More than 10,000 people have died in a West Africa epidemic of Ebola that dates back to December 2013, according to the World Health Organization.

    Biosafety Ebola Emerging Threats NIH
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleIn Pictures: Air National Guard CBRN Training
    Next Article Market Survey – Biothreat Environmental Sample Collection

    Related Stories

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023

    Pandemic Pushed 510,000 Kids in U.S. Into Grandparents’ Homes

    September 11, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy